Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India. Issue 4 (25th November 2021)

• Record Type: Journal Article
• Authors: Singh, Urvashi B.; Rophina, Mercy; Chaudhry, Rama; Senthivel, Vigneshwar; Bala, Kiran; Bhoyar, Rahul C.; Jolly, Bani; Jamshed, Nayer; Imran, Mohamed; Gupta, Ritu; Aggarwal, Praveen; Divakar, Mohit K.; Sinha, Subrata; Arvinden, V. R.; Bajaj, Anjali; Shamnath, Afra; Jain, Abhinav; Scaria, Vinod; Sivasubbu, Sridhar; Guleria, Randeep
• Other Names: Luo Guangxiang (George) guestEditor.; Ly Hinh guestEditor.; Gao Shou‐Jiang guestEditor.
• Is Part Of: Journal of medical virology. Volume 94:Issue 4(2022)
• Page Start: 1696
• Page End: 1700
• Publication Date: 2021-11-25
• Subjects: COVID‐19 -- genomic analysis -- SARS‐CoV‐2 -- vaccine breakthrough infections -- variants of concern; Virology -- Periodicals; 616
• DOI: 10.1002/jmv.27461
• Languages: English
• ISSNs: 0146-6615

Abstract

Abstract: Emerging reports of SARS‐CoV‐2 breakthrough infections entail methodical genomic surveillance for determining the efficacy of vaccines. This study elaborates genomic analysis of isolates from breakthrough infections following vaccination with AZD1222/Covishield and BBV152/Covaxin. Variants of concern B.1.617.2 and B.1.1.7 responsible for cases surge in April–May 2021 in Delhi, were the predominant lineages among breakthrough infections.